|
1
|
Muruve DA, Pétrilli V, Zaiss AK, White LR,
Clark SA, Ross PJ, Parks RJ and Tschopp J: The inflammasome
recognizes cytosolic microbial and host DNA and triggers an innate
immune response. Nature. 452:103–107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martinon F, Gaide O, Pétrilli V, Mayor A
and Tschopp J: NALP inflammasome: A central role in innate
immunity. Semin Immunopathol. 29:213–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tschopp J, Martinon F and Burns K: NALPs:
A novel protein family involved in inflammation. Nat Rev Mol Cell
Biol. 4:95–104. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ting JP, Lovering RC, Alnemri ES, Bertin
J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA,
et al: The NLR gene family: A standard nomenclature. Immunity.
28:285–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sidiropoulos PI, Goulielmos G, Voloudakis
GK, Petraki E and Boumpas DT: Inflammasomes and rheumatic diseases:
Evolving concepts. Ann Rheum Dis. 67:1382–1389. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Busso N and So A: Microcrystals as DAMPs
and their role in joint inflammation. Rheumatology (Oxford).
51:1154–1160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Varghese GP, Uporova L, Halfvarson J,
Sirsjö A and Fransén K: Polymorphism in the NLRP3
inflammasome-associated EIF2K2 gene and inflammatory bowel disease.
Mol Med Rep. 11:4579–4584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McDermott MF, Aksentijevich I, Galon J,
McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M,
Karenko L, Pettersson T, et al: Germline mutations in the
extracellular domains of the 55 kDa TNF receptor, TNFR1, define a
family of dominantly inherited autoinflammatory syndromes. Cell.
97:133–144. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Masters SL, Simon A, Aksentijevich I and
Kastner DL: Horror autoinflammaticus: The molecular pathophysiology
of autoinflammatory disease (*). Annu Rev Immunol. 27:621–668.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kastner DL, Aksentijevich I and
Goldbach-Mansky R: Autoinflammatory disease reloaded: A clinical
perspective. Cell. 140:784–790. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gerfaud-Valentin M, Jamilloux Y, Iwaz J
and Sève P: Adult-onset Still's disease. Autoimmun Rev. 13:708–722.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kadavath S and Efthimiou P: Adult-onset
Still's disease-pathogenesis, clinical manifestations, and new
treatment options. Ann Med. 47:6–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamaguchi M, Ohta A, Tsunematsu T,
Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K,
Matsumoto Y, Ota T, et al: Preliminary criteria for classification
of adult Still's disease. J Rheumatol. 19:424–430. 1992.PubMed/NCBI
|
|
15
|
Kawashima M, Yamamura M, Taniai M,
Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T
and Makino H: Levels of interleukin-18 and its binding inhibitors
in the blood circulation of patients with adult-onset Still's
disease. Arthritis Rheum. 44:550–560. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK,
Kim SS, Nahm DH and Park HS: Serum cytokine profiles in patients
with adult onset Still's disease. J Rheumatol. 30:2422–2427.
2003.PubMed/NCBI
|
|
17
|
Chen DY, Chen YM, Lan JL, Lin CC, Chen HH
and Hsieh CW: Potential role of Th17 cells in the pathogenesis of
adult-onset still's disease. Rheumatology (Oxford). 49:2305–2312.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Priori R, Barone F, Alessandri C,
Colafrancesco S, McInnes IB, Pitzalis C, Valesini G and Bombardieri
M: Markely increased IL-18 liver expression in adult-onset Still's
disease-related hepatitis. Rheumatology (Oxford). 50:776–780. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Young NS and Brown KE: Parvovirus B19. N
Engl J Med. 350:586–597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dorsch S, Liebisch G, Kaufmann B, von
Landenberg P, Hoffmann JH, Drobnik W and Modrow S: The VP1 unique
region of parvovirus B19 and its constituent phospholipase A2-like
activity. J Virol. 76:2014–2018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adamson-Small LA, Ignatovich IV,
Laemmerhirt MG and Hobbs JA: Persistent parvovirus B19 infection in
non-erythroid tissues: Possible role in the inflammatory and
disease process. Virus Res. 190:8–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen DY, Chen YM, Lan JL, Tzang BS, Lin CC
and Hsu TC: Significant association of past parvovirus B19
infection with cytopenia in both adult-onset Still's disease and
systemic lupus erythematosus patients. Clin Chim Acta. 413:855–860.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS
and Hsu TC: The association of VP1 unique region protein in acute
parvovirus B19 infection and anti-phospholipid antibody production.
Clin Chim Acta. 378:59–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pontillo A, Girardelli M, Kamada AJ,
Pancotto JA, Donadi EA, Crovella S and Sandrin-Garcia P:
Polymorphisms in inflammasome genes are involved in the
predisposition to systemic lupus erythematosus. Autoimmunity.
45:271–278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tschopp J and Schroder K: NLRP3
inflammasome activation: The convergence of multiple signaling
pathways on ROS production. Nat Rev Immunol. 10:210–215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bostanci N, Emingil G, Saygan B, Turkoglu
O, Atilla G, Curtis MA and Belibasakis GN: Expression and
regulation of the NALP3 inflammasome complex in periodontal
diseases. Clin Exp Immunol. 157:415–422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bruey JM, Bruey-Sedano N, Newman R,
Chandler S, Stehlik C and Reed JC: PAN1/NALP2/PYPAF2, an inducible
inflammatory mediator that regulates NF-kappaB and caspase-1
activation in macrophages. J Biol Chem. 279:51897–51907. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Radian AD, de Almeida L, Dorfleutner A and
Stehlik C: NLRP7 and related inflammasome activating pattern
recognition receptors and their function in host defense and
disease. Microbes Infect. 15:630–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khare S, Dorfleutner A, Bryan NB, Yun C,
Radian AD, de Almeida L, Rojanasakul Y and Stehlik C: An
NLRP7-containing inflammasome mediates recognition of microbial
lipopeptides in human macrophages. Immunity. 36:464–476. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kinoshita T, Wang Y, Hasegawa M, Imamura R
and Suda T: PYPAF3, a PYRIN-containing APAF-1-like protein, is a
feedback regulator of caspase-1-dependent interleukin-1beta
secretion. J Biol Chem. 280:21720–21725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pinheiro AS, Eibl C, Ekman-Vural Z,
Schwarzenbacher R and Peti W: The NLRP12 pyrin domain: Structure,
dynamics, and functional insights. J Mol Biol. 413:790–803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tadaki H, Saitsu H, Nishimura-Tadaki A,
Imagawa T, Kikuchi M, Hara R, Kaneko U, Kishi T, Miyamae T, Miyake
N, et al: De novo 19q13.42 duplications involving NLRP gene cluster
in a patient with systemic-onset juvenile idiopathic arthritis. J
Hum Genet. 56:343–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Y, Hasegawa M, Imamura R, Kinoshita
T, Kondo C, Konaka K and Suda T: PYNOD, a novel Apaf-1/CED4-like
protein is an inhibitor of ASC and caspase-1. Int Immunol.
16:777–786. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fernandes R, Tsuda C, Perumalsamy AL,
Naranian T, Chong J, Acton BM, Tong ZB, Nelson LM and Jurisicova A:
NLRP5 mediates mitochondrial function in mouse oocytes and embryos.
Biol Reprod. 86:138, 1–10. 2012. View Article : Google Scholar
|
|
37
|
Barlan AU, Griffin TM, McGuire KA and
Wiethoff CM: Adenovirus membrane penetration activates the NLRP3
inflammasome. J Virol. 85:146–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
